Medtech grants in Germany

Closed

Funds R&D on rapid tests that detect chemical and biological agents, including biotoxins.

Closed

Funds R&D on vaccines and drugs that protect against chemical, biological, radiological and nuclear threats.

Closed

Funds R&D on reusable respiratory protective equipment and protection suits against chemical, biological, radiological and nuclear threats.

Closed

Funds five projects, €5-6M each, that develop and test care approaches built around what cancer patients over 65 actually need during and after treatment.

Closed

Funds one €500K project that coordinates Europe's nuclear research network, connecting reactor science with medical and space uses of the field.

Closed

Funds one €2M project to build EU production of medical isotopes like ytterbium-176, cutting reliance on Russian supply for cancer radiopharmaceuticals.

Closed

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.

Closed

Funds research that measures wasteful or low-value healthcare practices and pilots ways to cut them, freeing up resources for care that actually helps patients.

Closed

Funds medical, technological and care research that prevents, reverses or reduces the severity of intellectual disability and supports the families who care for those affected.

Closed

Funds clinical trials of new drug-based therapies, paired with a complementary approach like neurostimulation or digital monitoring, for conditions such as depression, schizophrenia, PTSD and autism spectrum disorder.

Closed

Funds clinical trials that validate affordable, minimally-invasive surgery-centred treatments for cancer patients with locally advanced or metastatic disease.

Closed

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds multi-country clinical studies that generate the safety and performance data device makers need for CE marking of orphan or breakthrough medical devices.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.

Closed

Funds late-stage development of new diagnostic tests for vector-borne diseases such as those spread by mosquitoes and ticks.

Closed

Pays three European projects EUR 7.5 million each to develop advanced-materials sensors, from multifunctional surfaces to miniaturised wearable devices, with a guaranteed award in each of two research areas.

Closed

Funds research linking diet and nutrients to mental health, aiming at evidence and guidance for policymakers and health professionals.

Closed

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

Closed

Awards EUR 20,000 to a woman scientist recognised for global-health research and mentorship in sub-Saharan Africa.

Closed

Awards EUR 50,000 to a research team recognised for South-North global-health partnerships on poverty-related diseases.

Closed

Funds one project to map, replace, reduce and safely dispose of PFAS chemicals used in medicines, vaccines, devices and diagnostics.

Closed

Funds EU-wide work to pilot, roll out and evaluate lung cancer screening programmes, including AI-based detection tools.

Closed

Funds EU-wide piloting and rollout of prostate cancer screening programmes, including cross-border AI research on screening data.

Closed

Funds research proving the causal link between pollution exposure and neurological, neurodegenerative or neurodevelopmental disease, using biomarkers, imaging and long-term cohort data.